Patent Assignment
Reel/Frame 068339/0322
Assignment of Assignor's Interest
Recorded: 2024-08-07
Pages: 46
Assignor
SHIRE HUMAN GENETIC THERAPIES, INC.
Executed: 2022-07-11
Assignee
TAKEDA PHARMACEUTICAL COMPANY LIMITED
1-1, DOSHOMACHI 4-CHOME, CHUO-KU, OSAKA-SHI, 541-8645, JAPAN
Covered Property
(1)
Methods and Compositions for Treatment of Hunter Syndrome Comprising Iduronate-2-Sulfatase
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.